Martina Flammer helped advance brensocatib from development through FDA approval as the first DPP1 inhibitor for bronchiectasis. She is a 2026 Fierce 50 Breakthrough honoree. 🔗 @Insmed #Fierce50#

Noubar Afeyan has built a career around an unusual premise: Instead of waiting for the next biotech breakthrough, create the conditions for one. The Flagship Pioneering founder is a 2026 Fierce 50 Leadership honoree. 🔗 @FlagshipPioneer #Fierce50#

The 2026 Fierce 50 is live. This year’s honorees include leaders, scientists, companies and organizations changing how drugs are developed, healthcare is delivered and patients navigate the system. Meet the Fierce 50:

The 2026 Fierce 50 is live. Among this year’s honorees are scientists, biotech leaders and organizations pushing into new areas of drug development, diagnostics and patient care.